Related Experiment Videos
[Postoperative adjuvant immunochemotherapy with bestatin for stomach cancer. Randomized controlled trial: first
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|July 1, 1985
Abstract:
The effectiveness of Bestatin combined with Mitomycin-C, FT-207 for treating gastric cancer was investigated in a prospective randomized controlled study. All patients had undergone gastrectomy during the period from November 1980 to July 1983. Three-year survival rates revealed no difference between groups given or not given Bestatin. The effectiveness of Bestatin was confirmed by postoperative changes revealed by liver function test, especially GOT and GPT. No side effect due to Bestatin was detected.